These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 6087192

  • 1. Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitro.
    Rothman RB, Danks JA, Pert CB, Jacobson AE, Burke TR, Rice KC.
    Neuropeptides; 1984 May; 4(3):261-8. PubMed ID: 6087192
    [Abstract] [Full Text] [Related]

  • 2. Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model.
    Rothman RB, Bowen WD, Bykov V, Schumacher UK, Pert CB, Jacobson AE, Burke TR, Rice KC.
    Neuropeptides; 1984 May; 4(3):201-15. PubMed ID: 6087189
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intracerebroventricular administration of superFIT and its enantiomer to rats: evidence for in vivo acylation of [3H]DADL binding sites.
    Rothman RB, Long JB, Bykov V, Jacobson AE, Rice KC.
    Neuropeptides; 1987 Apr; 9(3):207-10. PubMed ID: 3037427
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
    Meunier JC, Kouakou Y, Puget A, Moisand C.
    Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437
    [Abstract] [Full Text] [Related]

  • 15. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography.
    Morris BJ, Millan MJ, Herz A.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828
    [Abstract] [Full Text] [Related]

  • 16. Multiple interconvertible affinity states for the delta opioid agonist-receptor complex.
    Spain JW, Coscia CJ.
    J Biol Chem; 1987 Jul 05; 262(19):8948-51. PubMed ID: 3036838
    [Abstract] [Full Text] [Related]

  • 17. Opioid-specific recognition sites of the mu- and the delta-type in rat striatum after lesions with kainic acid.
    Antkiewicz-Michaluk L, Havemann U, Vetulani J, Wellstein A, Kuschinsky K.
    Life Sci; 1984 Jul 23; 35(4):347-55. PubMed ID: 6087059
    [Abstract] [Full Text] [Related]

  • 18. Dimeric pentapeptide enkephalin: a novel probe of delta opiate receptors.
    Costa T, Shimohigashi Y, Krumins SA, Munson PJ, Rodbard D.
    Life Sci; 1982 Oct 11; 31(15):1625-32. PubMed ID: 6292643
    [Abstract] [Full Text] [Related]

  • 19. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes.
    Puttfarcken P, Werling LL, Brown SR, Cote TE, Cox BM.
    Mol Pharmacol; 1986 Aug 11; 30(2):81-9. PubMed ID: 3016503
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.